Diabytes
SII News
)
Cyrus Poonawalla founded the Serum Institute of India (SII) in 1966, which is today the world's largest vaccine manufacturer.
)
Covid-19 In India: India is in a better position to tackle the Covid crisis because of the government, healthcare workers and a common goal to tame the virus, said SII CEO Adar Poonawalla.
)
"There are over 300 subvariants of Omicron. I think the one that is concerning right now is XBB, which is a recombinant virus. We had seen some recombinant viruses earlier. It is very immune-evasive, which means it can overcome the antibodies. So slightly that we may see another wave of infections in some countries because of XBB," WHO said.
)
"Since December 2021, we have stopped the production of the Covishield vaccine. We had a stock of a few hundred million doses at that time and of that 100 million doses had already expired," Poonawalla said.
)
SII is in talks with Novovax to develop a vaccine against monkeypox
This has been confirmed by SII CEO Adar Poonawalla
He said that SII is working with Novovax to develop a messenger RNA for monkeypox
)
Serum Institute of India is considering setting up its first manufacturing plant in Africa
World`s biggest vaccine maker looks to expand globally after its success in selling Covid-19 shots.
'It`s never been a better time to be a vaccine manufacturer,' SII CEO Adar Poonawalla said at the World Economic Forum.
)
Adar Poonawalla clarified that the Covid-19 vaccine Covovax is available for everyone above the age of 12 years.
Earlier, on Tuesday, SII CEO had informed that Covovax (Novavax) is now available for children in India.
)
SII has slashed the price of each dose of Covovax
The price of each dose anti-Covid jab has been slashed from Rs 900 to Rs 225
SII CEO has said that Covovax is now available for children in India
)
The National Technical Advisory Group on Immunization (NTAGI) on Friday approved Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group, as per ANI.
)
Speaking to reporters on the sidelines of the ‘Alternate Fuel Conclave’, the SII CEO said the reason behind the low number of Covid-19 cases at the moment is that the country chose the right vaccine.
)
According to an official statement released by Novovax, the vaccine, also known as NVX-CoV2373, is manufactured and marketed in India by the Serum Institute of India (SII) under the brand name Covovax and is the first protein-based vaccine authorized for use in this age group in India.
)
"Novavax in global trials has demonstrated more than 90 per cent efficacy. Serum Institute of India`s brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults and for children above the age of 12. Younger age groups will follow shortly," SII CEO Adar Poonawala said in a tweet.
)
SII Chief Executive Officer Adar Poonawalla said COVID vaccines for children aged above 3 years will be launched in the next 6 months.
)
The Serum Institute of India is the first Indian company to seek approval for the COVID-19 booster dose.
The new Omicron variant was first reported to the WHO by South Africa on November 24.
)
The Serum Institute of India (SII) had put in an application to the Drugs Controller General of India (DCGI) in October for grant of market authorisation of Covovax for restricted use in emergency situations.
)
SII has urged the Centre to fast-track movement of Covishield domestically and globally.
SII can export 50 Lakh doses of Covishield under COVAX.
)
The government has also decided to allow the export of 10 million doses of a licensed version of the AstraZeneca shot made by SII, branded Covishield, to the global vaccine-sharing programme COVAX, two sources said.
)
Adar Poonawalla’s family-owned company SII is preparing to resume exports to the COVAX international vaccine sharing program for the first time since April.
)
Serum Institute of India has filed for WHO emergency use listing for its upcoming COVID vaccine Covovax.
The WHO has accepted the application of the Pune-based pharmaceutical company.
A pre-submission meeting was also held on August 10.
)
Serum Institute has communicated to Kolkata Police that the seized vials with labels of Covishield vaccine in the fake vaccine case in Kolkata was not Covishield vaccine. For further examination, Kolkata Police has sent those vials to Drug Controller for chemical examination.
Loading...
 "Will Hindus get justice in Bengal's Murshidabad?")
 "DNA: Uproar over freebies in Delhi!")
 "DNA: AIMIM plans to field 2020 Delhi riots accused Shahrukh Pathan")
 "DNA: A report showing the reality of Bangladesh")
 "DNA: Power Theft Allegations Against SP MP Ziaur Rahman Barq")
 "DNA: Hot Tea Linked to Cancer Risk!")
 "DNA: Why Jordan Fears After Syria’s Coup?")
 "DNA: NSA Ajit Doval’s China Visit - Inside Story")
 "DNA: Gandhi Family Ruined My Career, says Mani Shankar Aiyar")
 "DNA: Ground Report- Tight Security Arrangements for Mahakumbh")
